4-183245423-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024949.6(WWC2):āc.610A>Gā(p.Lys204Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000516 in 1,550,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024949.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWC2 | NM_024949.6 | c.610A>G | p.Lys204Glu | missense_variant | 6/23 | ENST00000403733.8 | NP_079225.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWC2 | ENST00000403733.8 | c.610A>G | p.Lys204Glu | missense_variant | 6/23 | 5 | NM_024949.6 | ENSP00000384222.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000329 AC: 6AN: 182486Hom.: 0 AF XY: 0.0000405 AC XY: 4AN XY: 98840
GnomAD4 exome AF: 0.00000501 AC: 7AN: 1398162Hom.: 0 Cov.: 30 AF XY: 0.00000577 AC XY: 4AN XY: 693656
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.610A>G (p.K204E) alteration is located in exon 6 (coding exon 6) of the WWC2 gene. This alteration results from a A to G substitution at nucleotide position 610, causing the lysine (K) at amino acid position 204 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at